Peritoneal cytology in the surgical evaluation of gastric carcinoma

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 520-524

  Hayes, N ^a   Wayman, J ^a   Wadehra, V ^b   Scott, Dj ^b   Raimes, Sa ^a   Griffin, Sm ^a,b  

^a Institute of Pathology   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Gastric cancer; Peritoneal cytology; Prognosis

Indexed keywords

ARTICLE; ASCITES FLUID CYTOLOGY; CYTOLOGY; DISSEMINATED CANCER; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; MICROSCOPY; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SEROSA; STOMACH CANCER;

ADULT; AGED; ASCITIC FLUID; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; PERITONEAL LAVAGE; PROGNOSIS; RECURRENCE; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0032924708     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690081     Document Type: Article

References (18)

1. Allum WH, Powell DJ, McConkey CC and Fielding JWL (1989a) Gastric cancer: a 25-year review. Br J Surg 76: 535-540
2. Allum WH, Hallissey MT, Ward LC and Hockey MS (1989b) A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. Br J Cancer 60: 739-744
3. Bonenkamp JJ, Songun I, Hermans J and van de Velde CJH (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 83: 672-674
4. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K and Yamamoto M (1990) Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77: 436-439
5. Cunliffe WJ and Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76: 1082-1090
6. Gunderson LL and Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathological correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8: 1-11
7. Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, Taniguchi H, Kitamura K, Noguchi A, Seiki K and Sakakura C (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339: 629-631
8. Hallissey M, Dunn J, Ward L and Allum W (1994) The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343: 1309-1312
9. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T and Koga S (1979) Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 44: 1476-1480
10. Kaibara N, Iitsuka Y, Kimura A, Kobayashi Y, Hirooka Y, Nishidoi H and Koga S (1987) Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 60: 136-139
11. Kennedy BJ (1987) The unified international gastric cancer staging classification system. Scand J Gastroenterol 22(suppl. 133): 11-13
12. Koss LG (1992) Diagnostic cytology and its histopathologic basis, 4th edn., pp. 126-137. JB Lippincott: Philadelphia
13. Murphy PD, Wadhera V, Griffith SM, Burgess P, Farrell D, Taylor I, Hair T, Clague MB and Griffith CDM (1993) Free peritoneal cell identification in patients with gastric and colorectal cancer. J R Coll Surg Edinburgh 38: 28-32
14. Nakajima T, Harashima S, Hirata M and Kajitani T (1978) Prognostic and therapeutic value of peritoneal cytology in gastric cancer. Acta Cytol 22: 225-229
15. Papachristou DN and Fortner JG (1981) Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol 18: 47-53
16. Soosay GN, Griffiths M, Papadaki L, Happerfield L and Bobrow L (1991) The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation. J Pathol 163: 299-305
17. Sue-Ling H, Johnston D, Martin IG, Dixon MF, Lansdown MRJ, McMahon MJ and Axon ATR (1993) Gastric cancer: a curable disease in Britain. Br Med J 307: 591-596
18. Sugarbaker PH, Cunliffe W, Belliveau JF, De Bruijn EA, Graves T, Mullins R, Schlag P and Gianola F (1988) Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1: 66-79